Overcoming Limitations of Cisplatin Therapy by Additional Treatment With the HSP90 Inhibitor Onalespib
Author:
Funder
Åke Wiberg Stiftelse
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference42 articles.
1. Cisplatin in cancer therapy: molecular mechanisms of action.;Dasari;Eur J Pharmacol.,2014
2. Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways.;Fuertes;Curr Med Chem.,2003
3. The side effects of platinum-based chemotherapy drugs: a review for chemists.;Oun;Dalton Trans.,2018
4. Ovarian cancer: beyond resistance.;Holmes;Nature.,2015
5. Molecular mechanisms of cisplatin resistance.;Galluzzi;Oncogene.,2012
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prevalence and predictors for cisplatin-induced toxicities in Zimbabwean women with cervical cancer;Future Oncology;2024-07-26
2. Cisplatin Resistance in Cancer Therapy: Causes and Overcoming Strategies;ChemistrySelect;2024-06-26
3. Combination therapy involving HSP90 inhibitors for combating cancer: an overview of clinical and preclinical progress;Archives of Pharmacal Research;2024-04-17
4. Heat shock protein 90: biological functions, diseases, and therapeutic targets;MedComm;2024-01-25
5. Favipiravir, an antiviral drug, in combination with tamoxifen exerts synergistic effect in tamoxifen-resistant breast cancer cells via hTERT inhibition;Scientific Reports;2024-01-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3